Targeting tumors with armed antibodies and with small targeted cytotoxics

Wed3  Sep09:15am(45 mins)
Charter 2
Keynote Speaker:


Antibodies can be used to deliver bioactive molecules (drugs, cytokines, photosensitizers, radionuclides, etc.) to the site of disease, sparing normal tissue. In addition, small organic molecules, capable of high-affinity binding to accessible markers of disease, may be used for pharmacodelivery applications.
In this lecture, I will present preclinical and clinical work performed in this field by our group, in collaboration with Philogen ( for the treatment of cancer and of chronic inflammatory conditions.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021